Table 2.
OR | P | |
---|---|---|
Univariate analysis | ||
dialysis duration (mo) | 1.01 | 0.2 |
age at the graft (yr) | 1.7 | 0.09 |
female (versus male) | 0.89 | 0.82 |
tacrolimus (versus cyclosporin) | 0.79 | 0.62 |
azathioprine (versus mycophenolate mofetil) | 3.2 | 0.02 |
induction with ATG | 1.55 | 0.39 |
HLA mismatches 2 to 4 versus 0 to 1 | 0.37 | 0.07 |
CMV R+ (versus D+ R− and D−R−) | 0.47 | 0.13 |
postgraft CMV infection | 0.68 | 0.45 |
no pre- and postgraft CMV infection | 4.3 | 0.009 |
delayed graft function | 0.68 | 0.42 |
acute rejection | 1.25 | 0.74 |
acute rejection treatment (ATG versus steroid) | 0.43 | 0.54 |
Multivariate analysis | ||
azathioprine (versus mycophenolate mofetil) | 3.76 | 0.01 |
no pre- or postgraft CMV infection | 5.28 | 0.006 |